News
You may sort news by title, date or business need. If you wish to detail your search, please select the categories from the left. If you wish to see events at which Quintiles is scheduled to participate, please select the events link from the top.
- Sort by:
- Most Recent
- Title
-
QUINTILES ANNOUNCES SUITE OF PI3K BIOMARKER ASSAYS TO ADVANCE ONCOLOGY THERAPIES TARGETING THIS CANCER PATHWAY
June 7, 2010 - Suite is part of Quintiles Global Central Labs’ ongoing efforts to advance personalized medicine.
-
QUINTILES ADDS TISSUE TESTING SERVICES IN CHINA
February 16, 2010 - Quintiles today announced the availability of anatomic pathology services through its central laboratory in Beijing, China, to help biopharmaceutical companies develop more effective cancer treatments.
-
QUINTILES ADVANCES CANCER TREATMENT THROUGH NEW GENETIC TESTS
May 26, 2009 – Targeted Molecular Diagnostics (TMD), a Quintiles Central Laboratory, announces the availability of two new laboratory tests used to develop more effective cancer treatments.
-
QUINTILES GLOBAL CENTRAL LABORATORY NETWORK SETS NEW STANDARD
March 11, 2009 – Quintiles Transnational Corp. has the largest CAP-accredited central laboratory network in the world - setting a standard for patient safety and faster drug development.
-
QUINTILES CENTRAL LAB IN ARGENTINA RECEIVES CAP ACCREDITATION
March 11, 2009 - Quintiles Central Lab in Buenos Aires is latest facility to be accredited in the world’s largest CAP-accredited lab network.
Page 1 of 1 (5 results)
